Integra LifeSciences (IART)
(Delayed Data from NSDQ)
$31.42 USD
+0.05 (0.16%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $31.41 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IART 31.42 +0.05(0.16%)
Will IART be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for IART based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IART
Inari Medical, Inc. (NARI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Earnings Preview: Integra LifeSciences (IART) Q2 Earnings Expected to Decline
IART: What are Zacks experts saying now?
Zacks Private Portfolio Services
Implied Volatility Surging for Integra (IART) Stock Options
Integra's (IART) New Site to Produce Recalled Tissue Products
Why Is Integra (IART) Up 26% Since Last Earnings Report?
Other News for IART
Alltrna Announces Updates to Its Board of Directors
Integra LifeSciences price target raised by $7 at Truist, here's why
Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts
First Week of IART August 16th Options Trading